Please login to the form below

Not currently logged in
Email:
Password:

Endocyte

This page shows the latest Endocyte news and features for those working in and with pharma, biotech and healthcare.

Novartis aims for 10 blockbuster launches by 2020

Novartis aims for 10 blockbuster launches by 2020

The year saw it spend $8.7bn on acquiring gene therapy company AveXis and radiotherapy specialists Endocyte for $2.8bn.

Latest news

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Novartis. Deal Type. Deal with. Details. Value. Acquisition. Endocyte. Portfolio of products and technology for. ... Endocyte’s adaptor controlled CAR‐T technology delivers the molecule FITC to the tumour through a tumour‐targeted ligand.

  • Charting a course for expansion Charting a course for expansion

    and eastern Europe - and US biotech Endocyte.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Endocyte appoints Parexel's Scot Harper to oversee clinical trials Endocyte appoints Parexel's Scot Harper to oversee clinical trials

    He also previously served at Novartis and Lilly. Endocyte has appointed Dr Scot Harper as VP, clinical operations, where he will be responsible for clinical trial operations at the US biopharma ... In addition, Endocyte says it has three new drug

  • Endocyte brings in senior figures from BMS and Amgen Endocyte brings in senior figures from BMS and Amgen

    The appointments come at a crucial time for Endocyte as it prepares for the approval and launch of cancer drugs vintafolide (in partnership with Merck &Co) and etarfolatide. ... The two additions follow the hire in July 2012 of Endocyte's first chief

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics